Fairvalue-Calculator Fairvalue-Calculator
EN DE

THC Farmaceuticals, Inc (CBDG) Fair Value & Analysis

Healthcare · US · Market cap $199K

Price$0.0110
Fair Value$0.0111
Upside+1.3%
Quality80/100
Evidence: Low Range $0.0107 – $0.0112

Fair value as of: Jun 26, 2026

✦ Find undervalued quality stocks — 34,000+ analysed Find stocks →

Analysis

THC Farmaceuticals, Inc (CBDG) currently trades at $0.0110, while our model-based Fair Value estimate is $0.0111 — implying the stock looks roughly 1.3% undervalued today. We read business quality at 80/100 (high quality), in the Healthcare sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: low) — always confirm before acting.

About the company

THC Farmaceuticals, Inc. owns and operates non-financial institution cash-dispensing automated teller machines at third-party owned retail and commercial locations. The company's machines are placed in hotels, stores, bowling alleys, and other high customer traffic areas for small and medium sized businesses. As of June 30, 2015, it had a total of eight machines for public use along the Wasatch Front in the State of Utah. The company was formerly known as City Media, Inc. and changed its name to THC Farmaceuticals, Inc. in February 2015. THC Farmaceuticals, Inc. was founded in 2008 and is based in Scottsdale, Arizona. THC Farmaceuticals, Inc. operates as a subsidiary of Weed Growth Fund, Inc.

Open the full interactive analysis →

Similar stocks

Frequently asked questions

Is THC Farmaceuticals, Inc (CBDG) undervalued?
As of Jun 26, 2026, our model estimates a fair value of $0.0111 versus a price of $0.0110 — about +1% (undervalued). Model-based estimate, not financial advice.
What is the fair value of CBDG?
Our 21-model fair value for THC Farmaceuticals, Inc is $0.0111 (as of Jun 26, 2026), built from audited fundamentals. The current price is $0.0110.
What is the quality score of CBDG?
THC Farmaceuticals, Inc has a Quality Score of 80/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.